Guervilly, Christophe http://orcid.org/0000-0001-9066-6591
Fournier, Théotime
Chommeloux, Juliette
Arnaud, Laurent
Pinglis, Camille
Baumstarck, Karine
Boucekine, Mohamed
Valera, Sabine
Sanz, Celine
Adda, Mélanie
Bobot, Mickaël
Daviet, Florence
Gragueb-Chatti, Ines
Forel, Jean-Marie
Roch, Antoine
Hraiech, Sami
Dignat-George, Françoise
Schmidt, Matthieu
Lacroix, Romaric
Papazian, Laurent
Clinical trials referenced in this document:
Documents that mention this clinical trial
Ultra-lung-protective ventilation and biotrauma in severe ARDS patients on veno-venous extracorporeal membrane oxygenation: a randomized controlled study
https://doi.org/10.1186/s13054-022-04272-x
Funding for this research was provided by:
Assistance Publique-Hôpitaux de Marseille (2018-A02297-48, 2018-A02297-48, 2018-A02297-48, 2018-A02297-48, 2018-A02297-48, 2018-A02297-48, 2018-A02297-48, 2018-A02297-48, 2018-A02297-48, 2018-A02297-48, 2018-A02297-48, 2018-A02297-48, 2018-A02297-48, 2018-A02297-48, 2018-A02297-48, 2018-A02297-48, 2018-A02297-48, 2018-A02297-48, 2018-A02297-48, 2018-A02297-48)
Article History
Received: 21 September 2022
Accepted: 9 December 2022
First Online: 12 December 2022
Declarations
:
: The study was approved by the ethical committee “comité de protection des personnes Ouest VI” on Mai 23th, 2019. According to French law, written informed consent was obtained from the patients or their proxies either before study inclusion or, for patients not competent to provide consent and with no available proxies, at recovery of competence.
: Not applicable.
: The authors declare the following interests: Christophe Guervilly reported personal consulting fees from Xenios FMC. Matthieu Schmidt received lecture fees from Getinge, Dräger, and Xenios. Françoise Dignat-George and Romaric Lacroix reported grants from Stago and a patent on microvesicle fibrinolytic activity licensed to Stago. Laurent Papazian received consultancy fees from Air Liquide MS, Faron and MSD. All these disclosures are outside the submitted work. The other authors declare no competing interests.